✦ LIBER ✦

Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer

✍ Scribed by Takuji Okusaka; Junji Furuse; Akihiro Funakoshi; Tatsuya Ioka; Kenji Yamao; Shinichi Ohkawa; Narikazu Boku; Yoshito Komatsu; Shoji Nakamori; Haruo Iguchi; Tetsuhide Ito; Kazuhiko Nakagawa; Kohei Nakachi

Book ID: 108586959
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 179 KB
Volume: 102
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2010.01810.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erlotinib plus gemcitabine in patients w

Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial

✍ Tomislav Dragovich; Mark Huberman; Daniel D. Von Hoff; Eric K. Rowinsky; Paul Na 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 310 KB

A phase II study of bevacizumab plus erl

A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer

✍ Andrew H. Ko; Alan P. Venook; Emily K. Bergsland; R. Kate Kelley; W. Michael Kor 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 266 KB

Phase II study of gemcitabine combined w

Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer

✍ Ron Epelbaum; Edward Rosenblatt; Suheil Nasrallah; David Faraggi; Dianna Gaitini 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

A phase I/II study of gemcitabine-based

A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

✍ Masashi Kanai; Kenichi Yoshimura; Masanori Asada; Atsushi Imaizumi; Chihiro Suzu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 263 KB

A multicenter phase II study of gemcitab

A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer

✍ Do-Youn Oh; Yongjun Cha; In-Sil Choi; So-Young Yoon; In Keun Choi; Jee Hyun Kim; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 352 KB

A phase II study of capecitabine plus ge

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer

✍ Hong Suk Song; Young Rok Do; Heung Moon Chang; Min Hee Ryu; Kyung Hee Lee; Yeul 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 271 KB